We||| Corne|| Med|ca| Co||ege 1he Method|st nosp|ta| nouston, 1exas D|sc|osure I have no con|ct of |nterest |n re|anon to th|s presentanon. Severa| o-|abe| uses of drugs w||| be mennoned. Cb[ecnves Descr|be phys|ca| and |aboratory hnd|ngs |n panents w|th |ntox|canon Cut||ne resusc|tanon and stab|||zanon measures D|scuss |ntervennons to decrease tox|n absorpnon and |ncrease e||m|nanon L|st |ntervennons and anndotes for se|ected tox|ns Management of Drug Cverdose kesusc|tanon and stab|||zanon D|agnos|s 1ox|n e||m|nanon Anndote and]or spec|hc |ntervennons Suppornve care D|agnos|s n|story Substance and quannty 1|me of |ngesnon Susta|ned-re|ease or regu|ar Acute or chron|c hys|ca| exam|nanon V|ta| s|gns Neuro|og|c hnd|ngs
V|ta| S|gns C|ues -8 0 8 neart kate 8|ood ressure 1emp ke|anve Change Amphetam|nes]coca|ne Anncho||nerg|cs Sympathom|mencs Narconcs Annhypertens|ves Sedanve]hypnoncs Increas|ng Decreas|ng Gastro|ntesnna| Decontam|nanon Ipecac - |nduced emes|s Catharncs Gastr|c |avage Who|e bowe| |rr|ganon Acnvated charcoa| Acnvated Charcoa| Dose: 1 g]kg Most eecnve w|th|n 1-2 h of |ngesnon May need nasogastr|c tube Not eecnve for: Iron Cyan|de L|th|um nydrocarbons A|coho|s Ac|d]A|ka||s L||m|nanon of 1ox|ns Mu|np|e doses of charcoa| 8arb|turates, theophy|||ne, carbamazep|ne, dapsone, qu|n|ne Iorced d|ures|s A|ka||ne d|ures|s (ur|ne pn>7) Sa||cy|ates, barb|turates, pr|m|done nemod|a|ys|s]hemoperfus|on Connnuous d|a|ys|s techn|ques 1. Wh|ch one of the fo||ow|ng agents |s most ||ke|y to resu|t |n death |n a po|soned panent?
A. Methamphetam|ne 8. I|uoxenne C. Lthano| D. Acetam|nophen L. Metopro|o| Deaths from o|son|ng (2011) Sedanve]hypnoncs]annpsychoncs 401 Acetam|nophen a|one (162) + comb|nanons (183) 34S Card|ovascu|ar drugs 30S Cp|o|ds 249 Anndepressants 229 Snmu|ants]street drugs 169 A|coho|s 147 Annconvu|sants 88 !!"#$%&'()% +,- (' ./0 ,/)% 1$2)3$/ 45647859:66 Acetam|nophen A|ways cons|der as a poss|b|e co|ngestant Un|ntennona| overdose occurs |n S0-61 of ||ver fa||ure cases 2S-33 of un|ntennona| overdoses take >1 acetam|nophen product Max|mum da||y dose of 3 g ohen exceeded k|sk factors: chron|c a|coho||sm, ma|nutr|non, drugs |nduc|ng C4S0 Acetam|nophen roducts 1y|eno| arthr|ns 6S0 mg 1y|eno| extra-strength S00 mg M|do| S00 mg Sudafed S|nus 32S mg V|cod|n LS 7S0 mg V|cod|n]Lortab S00 mg Darvocet-N100 6S0 mg Norco]U|tracet 32S mg Acetam|nophen (AA) Charcoa| |s eecnve |f g|ven ear|y Assess AA |eve| !4 h aher |ngesnon Use kumack-Mauhew nomogram to determ|ne tox|c|ty on|y |n &)%;/( .3<'( |ngesnons Assess transam|nases for mu|np|e or chron|c |ngesnons kumack-Mauhew Nomogram Acetam|nophen Anndote: ora| or IV N-acety|cyste|ne Most eecnve w|th|n 8 h Used up to 24 h aher |ngesnon Chron|c, mu|np|e or |ate |ngesnons Abnorma| transam|nases (>S0 IU]L) AA |eve| >10 g]mL (10 mo|]L) nepanc fa||ure present 2. Wh|ch of the fo||ow|ng agents resu|ts |n an osmo|ar gap and norma| an|on gap?
A.Methano| 8. L|th|um C.Lthy|ene g|yco| D.Lthy|ene g|yco| and ethano| L. Iron Metabo||c Ac|dos|s |n 1ox|co|ogy Lthy|ene g|yco| Methano| Sa||cy|ates Acetam|nophen Iron Carbon monox|de Cyan|de Va|pro|c ac|d ropofo| ropy|ene g|yco| Lthy|ene G|yco| and Methano| C||n|ca| hnd|ngs - CNS, GI, card|opu|monary symptoms Metabo||c hnd|ngs An|on gap metabo||c ac|dos|s Csmo|ar gap C|ues Cxa|ate crysta|s V|sua| d|sturbances www.||brary.med.utah.edu Metabo||sm of A|coho|s Lthy|ene g|yco| G|ycoa|dehyde Iorma|dehyde Iorm|c ac|d G|yco||c ac|d G|yoxy||c ac|d Methano| +/3$=$/ >(=?>#$;(%.&( Cxa||c ac|d Lthano| Lthy|ene G|yco| and Methano| Inh|b|non of a|coho| metabo||sm Lthano| (ora| or IV) Iomep|zo|e nemod|a|ys|s to remove a|coho| and metabo||tes Leve| >2S mg]dL Metabo||c ac|dos|s kena| fa||ure V|sua| symptoms
Lthy|ene G|yco| and Methano| Cther therapy Io||n|c ac|d (methano| tox|c|ty) 1h|am|ne Io|ate G|ucose 8|carbonate ropy|ene G|yco| 1ox|c|ty Most common|y occurs w|th |orazepam use for >3 dys Increased an|on gap and osmo|ar gap CNS depress|on or ag|tanon kena| dysfuncnon Se|zures Arrhythm|as nemo|ys|s ropy|ene G|yco| 1ox|c|ty Stop |orazepam or other drug Sedate w|th another agent M|dazo|am ropofo| Ientany| nemod|a|ys|s usua||y not requ|red 8enzod|azep|nes A|prazo|am common, ? more tox|c Anndote = umazen|| Not a subsntute for |ntubanon kesedanon concerns Contra|nd|canons Cyc||c anndepressants Chron|c benzod|azep|ne use 8radycard|a |n 1ox|co|ogy 8arb|turates "-8|ockers Ca|c|um channe| b|ockers C|on|d|ne Cho||nerg|c drugs (pyr|dosngm|ne) D|gox|n "-hydroxybutyrate Crganophosphates] carbamates Sedanve]hypnoncs "-8|ockers]Ca|c|um Channe| 8|ockers G|ucagon Ca|c|um (ch|or|de or g|uconate) Ventr|cu|ar pac|ng Atrop|ne, dopam|ne, ep|nephr|ne Insu||n eug|ycem|a (|nsu||n 0.1-10 U]kg]h + g|ucose 10-7S g]h) M||r|none L|p|d emu|s|on L|p|d Lmu|s|on as Anndote otenna| for use w|th ||poph|||c card|otox|c med|canons Used w|th |oca| anesthenc-|nduced arrest Most|y an|ma| stud|es]case reports Cyc||c anndepressants, verapam||, proprano|o|, ateno|o|, ha|oper|do|, organophosphates Coca|ne CV 1ox|c|ty Dysrhythm|as S|nus tachycard|a Ventr|cu|ar hbr|||anon] tachycard|a nypertens|on Aornc d|ssecnon Acute coronary syndromes Day 1 Day 3 Acute Coronary Syndromes Asp|r|n N|trog|ycer|n 8enzod|azep|nes hento|am|ne "-8|ockers (|n absence of acute sympathom|menc hnd|ngs) keperfus|on Cther Coca|ne 1ox|c|nes u|monary edema, bronchospasm, a|veo|ar hemorrhage Levam|so|e contam|nanon Intesnna| |schem|a]|nfarcnon kena| fa||ure khabdomyo|ys|s nypertherm|a !!@ +A ,$// B<#; 455C745D9E64 !!@ +A +3.> F(#A.'$/ 45667EG9655G Coca|ne No spec|hc anndote Ag|tanon 8enzod|azep|nes sychos|s na|oper|do| 1reat spec|hc comp||canons Amphetam|nes and Methamphetam|nes koutes - |nha|anon, snornng, IV, ora| Comp||canons Myocard|a| |schem|a Arrhythm|as Card|omyopathy Intracran|a| b|eed khabdomyo|ys|s Amphetam|nes and Methamphetam|nes Gastr|c empty|ng not he|pfu| Charcoa| has ||m|ted ro|e 8enzod|azep|nes for ag|tanon Suppornve care Annc|pate comp||canons 8ath Sa|ts Mephedrone, MDV (methy|ened|oxy- pyrova|erone), pyrova|erone Snmu|ant and ha||uc|nogen Snorted, |n[ected, |nha|ed Sympathom|menc eects, parano|a, aggress|ve behav|or Se|zures, rhabdomyo|ys|s, rena| fa||ure, stroke, hypertherm|a Sedanon w|th |orazepam, suppornve care www.freeads48.com Synthenc Mar|[uanas]Cannab|no|ds 8|nd to C8 receptors |n bra|n]sp|na| cord So|d as k2 and Sp|ce |n 2000s |n Germany Sp|ce re|eased by "1he syche De||" |n London Not detected |n ur|ne drug screens www.|ega|buds.com C||n|ca| Lects CNS: se|zures, ag|tanon, parano|a CV: tachycard|a, hypertens|on, |schem|a Autonom|c: fever, mydr|as|s Metabo||c: hypoka|em|a, hyperg|ycem|a GI: nausea, vom|nng kena|: acute k|dney |n[ury Muscu|oske|eta|: rhabdomyo|ys|s 3. A 30 year o|d w|th h|story of depress|on presents w|th AMS and the LkG be|ow.
Wh|ch one of the fo||ow|ng |ntervennons |s |nd|cated for the arrhythm|a? A. Am|odarone 8. Card|overs|on C. Magnes|um su|fate D. Sod|um b|carbonate L. Metopro|o| (Cyc||c) Anndepressants A|rway, card|ac mon|tor|ng Charcoa|, cons|der |avage 8|ood a|ka||n|zanon (pn 7.4S-7.SS)]sod|um |oad|ng nyperton|c sa||ne |n refractory cases Annarrhythm|c drugs Vasopressors - #-agon|st 8enzod|azep|nes for se|zures Cr|ter|a for 8|carbonate Use Card|ac conducnon de|ay kS >0.10 or 0.14 or 0.16 sec W|de comp|ex tachyarrhythm|a Card|ac arrest k|ght bund|e branch b|ock k avr !3 mm kefractory hypotens|on Cra| nypog|ycem|c Agents S0 g|ucose IV or ora|, then S or 10 g|ucose G|ucagon 1 mg SC or IM Cctreonde S0-100 g q 8h SC]IV Inh|b|ts |nsu||n re|ease Shortens hypog|ycem|c per|od L|th|um 1ox|c|ty (L| > 2.S - 4 mmo|]L) Centra| nervous system Arrhythm|as (|ess common) May cons|der who|e bowe| |rr|ganon Cpnm|ze |ntravascu|ar vo|ume Immed|ate and 2 h L| + |eve|s nemod|a|ys|s, connnuous rep|acement therap|es rescr|pnon Narconcs Cra|, snornng,IV use Deaths |ncreased 66 from 2001-200S (206 for methadone) Cxycodone, hydrocodone common|y d|verted Ientany| formu|anons ro|onged eects w|th susta|ned-re|ease forms Narconc Cverdose Anndote = Na|oxone IV, IM, SC, SL, endotrachea| 0.4 - 10 mg (h|gher doses for synthenc agents) t 1]2 = 4S-70 m|n Connnuous |nfus|on Suppornve care 1ramado| Lethargy, coma kesp|ratory depress|on Ag|tanon Se|zures 1achycard|a, n1N May cause fa|se (+) ur|ne tox|co|ogy for C Cho||nerg|c Syndrome Crganophosphates, carbamates Nerve gases (sar|n) SLUDGL man|festanons 8radycard|a, weakness 1reatment Atrop|ne (for secrenons) ra||dox|me (for weakness) 4. An ICU panent overdosed on a monoam|ne ox|dase |nh|b|tor and uoxenne. 1he panent |s de||r|ous, has had severa| se|zures, and has tremors of the extrem|nes. Wh|ch one of the fo||ow|ng shou|d be adm|n|stered? A. Dantro|ene 8. Lorazepam C. roprano|o| D. 8romocr|pnne L. na|oper|do|
www.herbmed.org www.mskcc.org]aboutherbs D|methy|amy|am|ne (DMAA) Supp|ement that |ncreases energy, concentranon and metabo||sm Structure s|m||ar to amphetam|nes Assoc|ated w|th deaths |n so|d|ers dur|ng exerc|se keports of ||ver and rena| fa||ure, se|zures, tachycard|a, n1N, |ntracran|a| hemorrhage, card|omyopathy nosp|ta|-Acqu|red Intox|canons GabapennnAMS, coma Narconcs nand san|nzersethano|, |sopropy| a|coho| Methemog|ob|nem|a$ top|ca| anesthencs ropy|ene g|yco| (|orazepam) ropofo| |nfus|on syndrome
ropofo| Infus|on Syndrome n|gh r|sk: Seps|s, |mpa|red C 2 de||very, head |n[ury, ICU panents w|th pro|onged |nfus|on of h|gh doses Can occur |n surg|ca| panents rece|v|ng |ow doses " C||n|ca| hnd|ngs: Myocard|a| fa||ure, arrhythm|as, |acnc ac|dos|s, hyperka|em|a, rhabdomyo|ys|s, rena| fa||ure, bradycard|a, hyper||pem|a Summary Use v|ta| s|gns and neuro|og|ca| hnd|ngs to suggest c|asses of tox|ns Lmcacy of GI decontam|nanon and tox|n e||m|nanon techn|ques |s ||m|ted Adm|n|ster |nd|cated anndotes for spec|hc tox|ns Lar|y adm|n|stranon of N-acety|cyste|ne prevents tox|c|ty |n acetam|nophen overdose Use benzod|azep|nes to contro| ag|tanon due to sympathom|menc tox|ns 1hank you for your auennon